Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Amerimmune to begin phase I/II study of AIDS drug in September

Aug. 10, 1999

Novel prodrugs of HIV protease inhibitors with potential to increase patient compliance

Aug. 10, 1999

Update on clinical progress of STGI's Anticort for AIDS

Aug. 9, 1999

Vitravene approved in E.U. for CMV retinitis

Aug. 6, 1999

DuPont introduces NNRTI in first major European market

Aug. 3, 1999

Further evidence of the efficacy of JE-2147, an improved HIV protease inhibitor

Aug. 3, 1999

Progenics awarded two grants from NIH for HIV programs

July 27, 1999

New depsipeptides produced by sponges possess anti-HIV and antitumor effects

July 22, 1999

Short-course nevirapine effective in reducing mother-to-infant transmission of HIV

July 20, 1999

Preliminary findings reported for combination HIV vaccine

July 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...